Dermatology / en The hidradenitis suppurativa (HS) Patient Partnership Summit: Empowering voices, uniting community /about-ucb/magazine/detail/article/the-hidradenitis-suppurativa-hs-patient-partnership-summit-empowering-voices-uniting-community <span>The hidradenitis suppurativa (HS) Patient Partnership Summit: Empowering voices, uniting community </span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Danuta Marchi, External Engagement, Immuno-Dermatology and Rheumatology </div> <span><span lang about="/user/9417" typeof="schema:Person" property="schema:name" datatype>Andrea_Puletto</span></span> <span><time datetime="2024-05-21T13:38:20+02:00" title="Tuesday 21 May 2024 - 13:38">Tue 21/05/2024 - 13:38</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2024-04/danuta.jpg.webp?itok=_OicVaON" width="158" height="132" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p>&nbsp;</p><p>In an unprecedented demonstration of solidarity and vision, the HS Patient Partnership Summit (15-16 April 2024) marked an important milestone in the hidradenitis suppurativa (HS) community’s efforts to address this chronic and painful disease. For two inspiring days, twenty representatives from HS patient advocacy groups around the world gathered to make connections, share knowledge and co-create together.</p><h2>A community united by empathy and purpose</h2><p>The ֳ-organized and funded Summit began with an atmosphere charged with empathy, as attendees shared their personal experiences of living with HS. Each story was a testament to the courage and determination that define the HS community. These narratives laid the groundwork for discussions that traversed the spectrum of patient care, from the challenges faced in securing an accurate diagnosis to the innovative approaches to treatment and support. We were reminded that people living with HS are not alone.</p><article data-quickedit-entity-id="media/45944" class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2024-05/picture1.png.webp?itok=Kdv3bain" width="897" height="236" typeof="foaf:Image"> </div> </article> <h2>Shared knowledge to drive meaningful change</h2><p>Participants shared their triumphs as well as the hurdles they’re trying to overcome in both advocacy and awareness-raising efforts within the HS community in order to learn from each other and advance their objectives. We heard how these advocates have illuminated the way forward through initiatives that empower patients and foster a deeper understanding of HS.</p><h2>The importance of correct information</h2><p>The critical need for correct information about HS was a resonant theme across all discussions. It was agreed that accurate information empowers patients to seek appropriate care, guides effective management and shapes the perceptions and understanding of the wider public to help overcome stigma. It’s the cornerstone upon which better health outcomes are built.&nbsp;</p><h2>Paving the way forward</h2><p>A collaborative spirit was palpable, as plans for future initiatives to increase global awareness and advance patient care took shape, marked by a commitment to collective action and patient-centered advocacy. The next steps are clear, we need to educate, gather data and, most importantly, empower patients to advocate for their care.</p><h2>A pioneering spirit to address HS</h2><p>The HS Patient Partnership Summit was more than an event—it was a clarion call to action and a demonstration of what can be achieved when empathy meets collaboration. As the summit concluded, participants clearly felt that this is just the beginning. The seeds of change were planted, ready to grow into a movement that promises to transform the landscape of HS care and advocacy.<br><br>Together, we look to the future with the pioneering spirit of the summit, ready to make our shared hope and vision a reality for the HS community around the world.</p> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1907" hreflang="en">about ucb</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1835" hreflang="en"> Hidradenitis Suppurativa</a> <a href="/taxonomy/term/10488" hreflang="en"> Hidradenitis Suppurativa partnership summit </a> <a href="/taxonomy/term/10446" hreflang="en">Dermatology</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=15018&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="bLoAG3ryEyrsQtoBTOXkE9b5d02gIB85Uo0Ka8Z818k"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/about-ucb/magazine/detail/article/the-hidradenitis-suppurativa-hs-patient-partnership-summit-empowering-voices-uniting-community" data-a2a-title="The hidradenitis suppurativa (HS) Patient Partnership Summit: Empowering voices, uniting community "><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Fabout-ucb%2Fmagazine%2Fdetail%2Farticle%2Fthe-hidradenitis-suppurativa-hs-patient-partnership-summit-empowering-voices-uniting-community&amp;title=The%20hidradenitis%20suppurativa%20%28HS%29%20Patient%20Partnership%20Summit%3A%20Empowering%20voices%2C%20uniting%20community%20"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNTAxOCIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiIzMTUiLCJkaXNsaWtlcyI6Ii0xNiJ9"></a> <span class="like-15018"> 315 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Tue, 21 May 2024 11:38:20 +0000 Andrea_Puletto 15018 at ֳ go ‘Under the Skin’ with new hidradenitis suppurativa (HS) podcast /about-ucb/magazine/detail/article/ucb-go-under-the-skin-with-new-hidradenitis-suppurativa-hs-podcast <span>ֳ go ‘Under the Skin’ with new hidradenitis suppurativa (HS) podcast</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Chiara Danelli, HS Dermatology </div> <span><span lang about="/user/8781" typeof="schema:Person" property="schema:name" datatype content="Vlastimil.Vanco@ucb.com">Vanco Vlastimi…</span></span> <span><time datetime="2023-11-07T09:00:00+01:00" title="Tuesday 7 November 2023 - 09:00">Tue 07/11/2023 - 09:00</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2023-11/Chiara%20Danelli.png.webp?itok=Y0vR2ypU" width="100" height="100" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p><br> As part of ֳ’s commitment to raising the standard of care for patients suffering with hidradenitis suppurativa (HS), ‘Under the Skin’, ֳ’s latest podcast series, draws back the curtain on this debilitating, chronic inflammatory skin disease. Aimed at healthcare professionals looking to learn more about HS, this podcast aims to shed light on this under-recognised disease, following the often complex patient journey from pre-diagnosis through to disease management. Hosted by Dr Barry McGrath (HS patient advocate and co-founder of HS Ireland) each episode in this five-part series invites a new expert guest to share their knowledge of treating HS and to discuss one of the many facets of the patient experience.&nbsp;<br> <br> All currently available episodes are listed below, and you can subscribe to the series on Spotify to catch all episodes as they’re released.<br> <br> Listen to our first episode, <a href="https://open.spotify.com/show/3Mr9COhSCj19kLFXzAHVto">“What is the bigger picture in HS?”</a> on Spotify now (<strong>for healthcare professionals only</strong>).<br> <br> <iframe allow="autoplay; clipboard-write; encrypted-media; fullscreen; picture-in-picture" allowfullscreen frameborder="0" height="352" loading="lazy" src="https://open.spotify.com/embed/episode/5e8EwsJqiuwRje1MsOEg6z?utm_source=generator" style="border-radius:12px" width="100%"></iframe><br> <br> Episode 1 welcomes Dr John Ingram (Consultant Dermatologist at Cardiff University) in conversation with our host Dr Barry McGrath (co-founder of HS Ireland) to share an overview of HS, its presentation in patients, epidemiology and global prevalence.<br> <br> Episode chapters:&nbsp;<br> Introducing Dr John Ingram<br> Background and pathobiology of HS<br> HS patient demographics<br> HS global and EU epidemiology<br> HS among other diseases<br> <br> Stay up to date with the latest ֳ news on our social media channels: <a href="https://www.linkedin.com/company/ucb-pharma/">LinkedIn </a>and <a href="https://twitter.com/ucb_news">X (Twitter)</a>.<br> <br> <em><u>Speaker disclosure</u></em>:</p> <p>Barry McGrath, PhD, has received consultancy/advisory board disease related honoraria from Novartis and ֳ.<br> &nbsp;</p> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1907" hreflang="en">about ucb</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/10453" hreflang="en">Under the Skin</a> <a href="/taxonomy/term/6001" hreflang="en">HS </a> <a href="/taxonomy/term/1835" hreflang="en"> Hidradenitis Suppurativa</a> <a href="/taxonomy/term/10443" hreflang="en">Chronic inflammatory diseases</a> <a href="/taxonomy/term/10446" hreflang="en">Dermatology</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=14899&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="qL3JZsQsX7WzGVTNbKBJyATf8Z9o66v4NzmgR74aRuw"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/about-ucb/magazine/detail/article/ucb-go-under-the-skin-with-new-hidradenitis-suppurativa-hs-podcast" data-a2a-title="ֳ go ‘Under the Skin’ with new hidradenitis suppurativa (HS) podcast"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Fabout-ucb%2Fmagazine%2Fdetail%2Farticle%2Fucb-go-under-the-skin-with-new-hidradenitis-suppurativa-hs-podcast&amp;title=ֳ%20go%20%E2%80%98Under%20the%20Skin%E2%80%99%20with%20new%20hidradenitis%20suppurativa%20%28HS%29%20podcast"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNDg5OSIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI0NTUiLCJkaXNsaWtlcyI6Ii01MiJ9"></a> <span class="like-14899"> 455 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Tue, 07 Nov 2023 08:00:00 +0000 Vanco Vlastimil (ֳ S.A.) 14899 at Evolving Expectations for Dermatological Conditions /about-ucb/magazine/detail/article/evolving-expectations-for-dermatological-conditions <span>Evolving Expectations for Dermatological Conditions</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Camille Lee, U.S. Immunology </div> <span><span lang about="/user/8781" typeof="schema:Person" property="schema:name" datatype content="Vlastimil.Vanco@ucb.com">Vanco Vlastimi…</span></span> <span><time datetime="2023-10-18T17:28:14+02:00" title="Wednesday 18 October 2023 - 17:28">Wed 18/10/2023 - 17:28</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2023-10/Camille%20Lee.png.webp?itok=EFr4hua5" width="81" height="100" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p><br> Upon joining the team at ֳ over four years ago, I was immediately inspired by everyone’s commitment to and passion for creating differentiated solutions for people living with severe and chronic diseases. I have always found my motivation in empowering people to manage their health, so their life can be the focus, not their disease. At ֳ, we consider each person’s journey to help them achieve their own goals and live their best possible life.<br> <br> Part of what I’ve found makes ֳ unique is the robust research, both quantitative and qualitative, that goes into understanding the patient journey and needs, and applying these insights in every stage of the clinical development and commercialization process. We talk with people living with psoriasis and listen to what they experience, which helps us appreciate the impact it can have on their physical and emotional well-being.<br> <br> At the surface, psoriasis is one of the most common autoimmune disorders, affecting approximately 7.5 million people in the U.S. alone. It causes rapid build-up of extra skin cells that form thick, silvery scales and itchy, dry, red patches. But when you dig deeper, you learn that psoriasis is more than a skin disease.<br> <br> We have heard that after receiving a psoriasis diagnosis, many people feel forcibly displaced from their sense of self. People living with psoriasis often report negative mental health and social well-being, and through an online survey of 500 adult patients in the U.S., more than 90% of people with a moderate-to-severe form of the condition feel their psoriasis has a significant impact on their quality of life. They begin their care journey and oftentimes feel there is no clear destination or relief. More than half of patients being treated for moderate-to-severe plaque psoriasis don’t feel that they are achieving clear or almost clear skin and, more importantly, many of these patients do not believe this to be a realistic treatment goal. &nbsp;People living with psoriasis deserve better.<br> <br> At ֳ, we refuse to accept the conventional expectations for skin clearance. We know that increased levels of skin clearance are correlated with improvements in quality of life. Because of this, we are committed to creating accessible treatments that empower people with psoriasis to expect more from their treatment.<br> <br> I’m excited by our progress in delivering these solutions and look forward to seeing the impact on the dermatology community.&nbsp;<br> &nbsp;</p> <article data-quickedit-entity-id="media/45290" class="align-center media media--type-video media--view-mode-embedded"> <div class="field field--name-field-media-video-embed-field field--type-video-embed-field field--label-hidden field__items"> <div class="video-embed-field-provider-vimeo video-embed-field-responsive-video"><iframe width="854" height="480" frameborder="0" allowfullscreen="allowfullscreen" src="https://player.vimeo.com/video/875625244?autoplay=0"></iframe> </div> </div> </article> <p>&nbsp;</p> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1907" hreflang="en">about ucb</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/10446" hreflang="en">Dermatology</a> <a href="/taxonomy/term/1564" hreflang="en">psoriasis</a> <a href="/taxonomy/term/1226" hreflang="en">Patients</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=14891&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="AoOi1HiILoxKT-UPwqWBDIz55R-ZP0pEVjgJYYPEOg8"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/about-ucb/magazine/detail/article/evolving-expectations-for-dermatological-conditions" data-a2a-title="Evolving Expectations for Dermatological Conditions"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Fabout-ucb%2Fmagazine%2Fdetail%2Farticle%2Fevolving-expectations-for-dermatological-conditions&amp;title=Evolving%20Expectations%20for%20Dermatological%20Conditions"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNDg5MSIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI0MTQiLCJkaXNsaWtlcyI6Ii02MSJ9"></a> <span class="like-14891"> 414 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Wed, 18 Oct 2023 15:28:14 +0000 Vanco Vlastimil (ֳ S.A.) 14891 at